Danaher Co. (NYSE:DHR) Shares Acquired by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. increased its stake in Danaher Co. (NYSE:DHR) by 5.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,717 shares of the conglomerate’s stock after acquiring an additional 795 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Danaher were worth $3,636,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Nicholas Hoffman & Company LLC. raised its stake in Danaher by 2.3% during the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock valued at $439,000 after acquiring an additional 43 shares during the last quarter. Drive Wealth Management LLC raised its stake in Danaher by 3.1% during the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock valued at $344,000 after acquiring an additional 44 shares during the last quarter. Trust Investment Advisors raised its stake in Danaher by 1.8% during the 4th quarter. Trust Investment Advisors now owns 2,811 shares of the conglomerate’s stock valued at $650,000 after acquiring an additional 49 shares during the last quarter. Connolly Sarah T. raised its stake in Danaher by 0.5% during the 3rd quarter. Connolly Sarah T. now owns 9,599 shares of the conglomerate’s stock valued at $2,382,000 after acquiring an additional 50 shares during the last quarter. Finally, Austin Private Wealth LLC raised its stake in Danaher by 3.4% during the 3rd quarter. Austin Private Wealth LLC now owns 1,566 shares of the conglomerate’s stock valued at $389,000 after acquiring an additional 51 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

NYSE:DHR traded down $2.70 during trading hours on Wednesday, reaching $250.41. 3,064,441 shares of the company traded hands, compared to its average volume of 2,783,958. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $259.00. The stock has a market cap of $185.44 billion, a P/E ratio of 39.19, a P/E/G ratio of 3.96 and a beta of 0.83. The firm’s 50-day moving average is $249.00 and its 200-day moving average is $230.78. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same quarter in the prior year, the company posted $2.36 EPS. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. Equities research analysts expect that Danaher Co. will post 7.62 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Thursday, March 28th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date is Wednesday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.24. Danaher’s dividend payout ratio is currently 16.90%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on DHR. Citigroup boosted their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday. Royal Bank of Canada boosted their target price on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Robert W. Baird boosted their target price on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and upped their price target for the stock from $250.00 to $280.00 in a report on Wednesday, April 17th. Finally, KeyCorp upped their price target on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Six equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $270.00.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 3,289 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the transaction, the director now owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director Teri List sold 3,289 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total value of $816,724.48. Following the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Daniel Raskas sold 23,757 shares of the stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the transaction, the senior vice president now directly owns 38,102 shares in the company, valued at $9,601,704. The disclosure for this sale can be found here. Insiders have sold a total of 32,957 shares of company stock valued at $8,265,802 in the last quarter. 10.90% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.